A 58-year-old man with a 15-year history of alcohol use disorder presents to the emergency department with hematemesis and melena. On examination, he is tachycardic (HR 110/min), hypotensive (BP 88/54 mmHg), and has clinical signs of cirrhosis including jaundice, spider angiomata, and ascites. Upper endoscopy reveals large esophageal varices with active bleeding. After initial resuscitation and blood transfusion, variceal bleeding is controlled endoscopically with band ligation. Which of the following is the most appropriate next step in management to prevent rebleeding?

Explanation

## Management of Esophageal Variceal Bleeding — Prevention of Rebleeding ### Acute Phase vs. Long-term Strategy **Key Point:** After successful endoscopic control of variceal hemorrhage, the next priority is prevention of rebleeding through pharmacological and endoscopic means. Repeat band ligation and beta-blocker therapy form the cornerstone of secondary prophylaxis. ### Rationale for Propranolol **High-Yield:** Beta-blockers (propranolol, carvedilol, or nadolol) reduce portal pressure by decreasing splanchnic blood flow and cardiac output. They reduce the risk of rebleeding by approximately 40% and improve survival in cirrhotic patients with varices. **Clinical Pearl:** Propranolol is initiated immediately after acute bleeding control and continued indefinitely. The target is to reduce the heart rate by 25% or to a heart rate of 55–60 bpm, or to reduce the hepatic venous pressure gradient (HVPG) by ≥20%. ### Endoscopic Band Ligation Schedule Repeat endoscopic band ligation is performed at 1–2 week intervals until variceal eradication is achieved (typically 2–4 sessions). However, this is done *in addition to* beta-blocker therapy, not instead of it. ### Why Other Options Are Incorrect | Option | Why It Is Not the Best Next Step | | --- | --- | | Repeat EBL alone (1–2 weeks) | Correct timing for repeat EBL, but incomplete without pharmacological prophylaxis; beta-blockers must be started immediately | | Ceftriaxone + lactulose | These are adjunctive measures for preventing spontaneous bacterial peritonitis and hepatic encephalopathy, not primary rebleeding prevention | | Immediate TIPS | Reserved for TIPS-refractory variceal bleeding (failure of endoscopy + pharmacotherapy) or for acute variceal bleeding in patients with decompensated cirrhosis and high risk of early rebleeding; not first-line after successful EBL | ### Treatment Algorithm for Variceal Bleeding ```mermaid flowchart TD A["Esophageal variceal bleeding confirmed"]:::outcome --> B["Acute resuscitation + blood products"]:::action B --> C["Endoscopic band ligation"]:::action C --> D{"Bleeding controlled?"}:::decision D -->|Yes| E["Start beta-blocker immediately"]:::action D -->|No| F["Repeat EBL or consider TIPS"]:::action E --> G["Repeat EBL at 1-2 weeks"]:::action G --> H{"Varices eradicated?"}:::decision H -->|Yes| I["Continue beta-blocker indefinitely"]:::action H -->|No| J["Repeat EBL sessions until eradication"]:::action F --> K["TIPS for refractory bleeding"]:::urgent ``` **Mnemonic:** **REBLEED** — **R**esuscitate, **E**ndoscopy with band ligation, **B**eta-blockers start immediately, **L**igations repeated, **E**radication of varices, **E**ndoscopy surveillance, **D**efinitive prophylaxis (beta-blockers for life). ### Additional Supportive Measures - **Variceal ligation** is superior to sclerotherapy for long-term outcomes (lower rebleeding rates, lower mortality). - **Antibiotic prophylaxis** (ceftriaxone or norfloxacin) is given during acute bleeding to reduce bacterial infections and improve survival, but is not the primary rebleeding prevention strategy. - **TIPS** is reserved for refractory variceal bleeding or early rebleeding despite optimal medical and endoscopic therapy.